You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHB

Showing 1 - 25 of 878
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-bet B Cells in Persistent Virus Control After Discontinuance

Completed
  • Chronic HBV Infection
  • Drug Withdrawal
  • T-bet B cell
  • Shanghai, China
    Changhai hospital
Sep 1, 2023

Efficacy, Safety, Pharmacokinetics Trial in Jilin (Hepenofovir Fumarate Tablets)

Recruiting
  • Efficacy
  • +2 more
  • Hepenofovir Fumarate Tablets
  • Jilin, Changchun, China
    The First Hospital of Jilin University
Nov 2, 2023

Chronic Hepatitis b Trial (RBD1016, RBD1016+PegIFN-a)

Not yet recruiting
  • Chronic Hepatitis b
  • (no location specified)
Jul 25, 2023

Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)

Recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +47 more
Jan 24, 2023

Hepatic Inflammation, Fibrosis and Prognosis in CHB and NAFLD

Recruiting
  • Chronic Hepatitis b
  • Non-alcoholic Fatty Liver Disease
    • Nanjing, China
      Nanjing Drum Tower Hospital
    Mar 2, 2023

    Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

    Not yet recruiting
    • Chronic Hepatitis b
    • Auckland, New Zealand
      New Zealand Clinical Research Auckland
    Jul 26, 2023

    Chronic Hepatitis B Trial in Hong Kong (Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV

    Recruiting
    • Chronic Hepatitis B
    • Stop current treatment (anti-HBV neucleos(t)ides)
    • Keep current treatment (anti-HBV neucleos(t)ides)
    • Hong Kong, Hong Kong SAR, Hong Kong
      Humanity & Health Research Centre
    Mar 16, 2022

    Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis

    Recruiting
    • Chronic Hepatitis b
    • test of HBV DNA
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an JiaotongUniversity
    Mar 28, 2022

    Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Tenofovir disoproxil fumarate
    • Toronto, Ontario, Canada
      University Health Network - Toronto General Hospital
    Nov 1, 2022

    Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)

    Not yet recruiting
    • Chronic Hepatitis B
    • GS-2829
    • +3 more
    • (no location specified)
    Mar 14, 2023

    Chronic Hepatitis b Trial in Changchun (GST-HG141)

    Recruiting
    • Chronic Hepatitis b
    • Changchun, Jilin, China
      The first hospital of Jilin University
    Dec 5, 2022

    Chronic Hepatitis B Trial in Hong Kong (Tenofovir alafenamide(TAF), Tenofovir disoproxil fumarate(TDF))

    Recruiting
    • Chronic Hepatitis B
    • Tenofovir alafenamide(TAF)
    • Tenofovir disoproxil fumarate(TDF)
    • Hong Kong, Hong Kong
      Humanity and Health GI and Liver Centre
    Dec 19, 2022

    Patients With Chronic Hepatitis B (CHB) Infection

    Recruiting
    • Hepatitis B
    • +2 more
    • All approved therapies for the treatment of Chronic Hepatitis B (CHB)
    • Phoenix, Arizona
    • +30 more
    Jan 27, 2023

    Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

    Completed
    • Chronic Hepatitis b
    • Vitamin D
    • Guangzhou, Guangdong, China
      Department of Infectious Diseases, The Third Affliated Hospital
    Mar 2, 2023

    HBeAg-negative CHB Patients With Indeterminate Phase

    Recruiting
    • Chronic Hepatitis b
    • Observation
    • Antiviral treatment
    • Changzhou, Jiangsu, China
    • +4 more
    Dec 21, 2022

    Parathyroid Hormone, Tenofovir Disoproxil Fumarate, Chronic Hepatitis, B Virus Without Hepatitis Delta (Diagnosis) Trial in

    Not yet recruiting
    • Parathyroid Hormone
    • +3 more
    • Ergocalciferol Capsules
    • Calcium carbonate
    • Bangkok Noi, Bangkok, Thailand
      Faculty of Medicine Siriraj Hospital, Mahidol University
    Mar 28, 2022

    Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

    Not yet recruiting
    • Chronic Hepatitis B
    • PEG IFN α-2b; TAF
    • (no location specified)
    Aug 5, 2022

    TAF for 48 Weeks in HBeAg Positive CHB Patients

    Recruiting
    • Chronic Hepatitis B
    • Tenofovir Alafenamide 25 MG [Vemlidy]
    • Shanghai, China
    • +2 more
    Sep 5, 2021

    Chronic Hepatitis B, Hepatic Fibrosis, Fatty Liver Trial in Seoul

    Active, not recruiting
    • Chronic Hepatitis B
    • +2 more
      • Seoul, Korea, Republic of
        Seoul Metropolitan Government Seoul National University
      May 3, 2022

      Hepatitis B, Chronic Trial in Changchun (drug, other, combination product)

      Not yet recruiting
      • Hepatitis B, Chronic
      • Changchun, Jilin, China
        The First Hospital of Jilin University
      Jul 29, 2022

      Chronic Hepatitis B Trial in Hong Kong, Korea, Republic of (Inarigivir Soproxil, TAF)

      Terminated
      Has Results
      • Chronic Hepatitis B
      • Inarigivir Soproxil
      • TAF
      • Hong Kong, Hong Kong
      • +12 more
      Mar 8, 2022

      Renal Insufficiency, Tenofovir Trial in Bangkok Noi (Switching to Tenofovir Alafenamide)

      Recruiting
      • Renal Insufficiency
      • Tenofovir
      • Switching to Tenofovir Alafenamide
      • Bangkok Noi, Bangkok, Thailand
        Faculty of Medicine Siriraj Hospital, Mahidol University
      Mar 7, 2022

      Hepatitis B, Chronic Trial in China (Tenofovir disoproxil fumarate)

      Completed
      Has Results
      • Hepatitis B, Chronic
      • Tenofovir disoproxil fumarate
      • Guangzhou, Guangdong, China
      • +18 more
      Nov 26, 2021

      Chronic Hepatitis B Trial in Worldwide (ALG-000184, Placebo)

      Recruiting
      • Chronic Hepatitis B
      • Guangzhou, Guangdong, China
      • +5 more
      Nov 17, 2022

      Chronic Hepatitis b Trial in China (Integrated intervention strategies)

      Not yet recruiting
      • Chronic Hepatitis b
      • Integrated intervention strategies
      • Changzhou, Jiangsu, China
      • +3 more
      Jul 21, 2021